Fiona Murray
About Fiona Murray
Fiona Murray is the Head of Regulatory CMC at AlloVir, a position she has held since 2021 in Ireland. She has previous experience in regulatory affairs at Genzyme and Sanofi, and holds a Bachelor of Science in Biotechnology from Dublin City University.
Work at AlloVir
Fiona Murray serves as the Head of Regulatory CMC at AlloVir since 2021. In this role, she oversees regulatory strategies and compliance related to Chemistry, Manufacturing, and Controls (CMC) for the company's product pipeline. Her position is critical in ensuring that AlloVir meets all regulatory requirements while advancing its innovative therapies.
Previous Experience in Regulatory Affairs
Prior to her current role, Fiona Murray worked at Sanofi as Senior Director of Global Regulatory Affairs CMC Biologic Products from 2017 to 2021. In this capacity, she led regulatory initiatives for biologic products, focusing on CMC aspects to ensure compliance with global regulations. Earlier in her career, she spent two years at Genzyme in Australia, where she gained foundational experience in regulatory affairs from 2001 to 2003.
Education and Expertise
Fiona Murray holds a Bachelor of Science (B.Sc.) degree in Biotechnology from Dublin City University. Her educational background provides her with a strong foundation in the scientific principles underlying biotechnology and regulatory processes, contributing to her expertise in the field of regulatory affairs.
Career Timeline
Fiona Murray's career spans over two decades in the regulatory affairs sector. She began her professional journey at Genzyme from 2001 to 2003, followed by a significant tenure at Sanofi from 2017 to 2021. Since 2021, she has been with AlloVir, where she continues to influence regulatory strategies in the biotechnology industry.